XM does not provide services to residents of the United States of America.
W
W

Wacker


News

Pearson, Softcat, Trelleborg

EUROPE RESEARCH ROUNDUP- Pearson, Softcat, Trelleborg July 5 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Pearson, Softcat and Trelleborg, on Friday. HIGHLIGHTS * Aker BP ASA AKRBP.OL : Jefferies cuts target price to NOK 340 from NOK 345 * GSK GSK.L : Citigroup cuts target price to 1900p from 2120p * Pearson PSON.L : Deutsche Bank raises target price to 1052p from 1050p * Softcat Plc SCTS.L : Jefferies cuts target price to 1,490
A
A
B
C
C
D
D
E
E
G
I
K
N
N
P
T
T
T
V
W
A
D
Y

JPM puts Wacker Chemie on negative catalyst watch as polysilicon prices worry

BUZZ-JPM puts Wacker Chemie on negative catalyst watch as polysilicon prices worry ** J.P.Morgan places German chemical firm Wacker Chemie WCHG.DE on its Negative Catalyst Watch, expecting material cuts to estimates post Q2 results due to the recent collapse in polysilicon prices ** JPM expects polysilicon prices to recover the coming quarters, however not probably above Wacker Chemie cash cost levels due to the very significant oversupply ** The broker notes Wacker's customers for polysilicon a
J
W
J

Baader's European chemicals picks for H2 as sector faces gradual recovery

BUZZ-Baader's European chemicals picks for H2 as sector faces gradual recovery ** Baader Helvea sees a gradual recovery ahead for the European chemicals sector, and says it favours speciality and special situations chemical companies over diversified ones ** Diversified and higher volume chemical stocks underwent a price correction during Q2, while
B
C
G
W

Admiral, Maersk, Raspberry PI

EUROPE RESEARCH ROUNDUP-Admiral, Maersk, Raspberry PI June 25 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Admiral, Maersk and Raspberry, on Tuesday. HIGHLIGHTS * Admiral ADML.L : Berenberg raises to buy from hold; raises PT to 3,127p from 2,973p * Direct Line Insurance DLGD.L : Berenberg cuts to hold from buy * IMI Plc IMI.L : JP Morgan raises target price to 2,200p from 1,850p * Maersk MAERSKb.CO : Morgan Stanley raises target
3
A
A
B
B
C
E
G
H
H
I
K
K
K
L
M
M
N
O
S
S
W
D
R

Wacker Chemie: Construction Of New Production Site In Czech Republic

BRIEF-Wacker Chemie: Construction Of New Production Site In Czech Republic June 20 (Reuters) - WACKER CHEMIE AG WCHG.DE : STRENGTHENS FOCUS ON SILICONE SPECIALTIES WITH THE CONSTRUCTION OF A NEW PRODUCTION SITE IN THE CZECH REPUBLIC THE INVESTMENT VOLUME IS IN THE LOW TRIPLE-DIGIT MILLION-EURO RANGE 200 NEW JOBS WILL BE CREATED IN THE FIRST EXPANSI
W

Wacker Chemie Wacker Opens Mrna Competence Center

BRIEF-Wacker Chemie AG - Wacker Opens Mrna Competence Center June 3 (Reuters) - WACKER CHEMIE AG WCHG.DE : WACKER OPENS MRNA COMPETENCE CENTER IN HALLE AN DER SAALE, GERMANY SOME OF NEW CAPACITY WILL BE MADE AVAILABLE TO GERMAN GOVERNMENT AS PART OF ITS PANDEMIC-PREPAREDNESS PLAN IN ORDER TO RAPIDLY SUPPLY GERMANY WITH VACCINES AS AND WHEN REQUIRED
W

Wacker Chemie Acquires Manufacturing Assets And Know-How Of Bio Med Sciences

BRIEF-Wacker Chemie Acquires Manufacturing Assets And Know-How Of Bio Med Sciences May 31 (Reuters) - WACKER CHEMIE AG WCHG.DE : WACKER POSITIONS ITSELF AS SOLUTION PROVIDER FOR SILICONE-COATED HEALTHCARE PRODUCTS WITH NEW ACQUISITION BOTH PARTIES HAVE AGREED NOT TO DISCLOSE THE PURCHASE PRICE AS PART OF THE ACQUISITION, A MAJORITY OF BIO MED SCIENCES’ WORKFORCE WILL ALSO MOVE TO WACKER HAS ACQUIRED MANUFACTURING ASSETS AND KNOW-HOW OF U.S.-BASED BIO MED SCIENCES INC.
W

Germany's chemicals sector sees signs of recovery as demand picks up

Germany's chemicals sector sees signs of recovery as demand picks up By Tristan Veyet and Bartosz Dabrowski May 15 (Reuters) - After a couple of tough years, some German chemicals makers saw signs of recovery in orders and volumes in the first quarter, driven by the improving economic situation and higher demand outside of Europe. The industry in Germany, Europe's largest chemicals producer, suffered heavily throughout 2023 due to high production costs and weak demand amidst high inflation.
B
K
L
W

Wacker Chemie Confirms FY 2024 Outlook and Adopts AGM Proposals

BRIEF-Wacker Chemie Confirms FY 2024 Outlook and Adopts AGM Proposals May 8 (Reuters) - WACKER CHEMIE AG WCHG.DE : 2024 ANNUAL SHAREHOLDERS’ MEETING ADOPTS ALL EXECUTIVE AND SUPERVISORY BOARD PROPOSALS OUTLOOK FOR FULL-YEAR 2024 CONFIRMED Further company coverage: WCHG.DE (Gdansk Newsroom)
W

Wacker Expands Production Capacity For Biopharmaceuticals In San Diego

BRIEF-Wacker Expands Production Capacity For Biopharmaceuticals In San Diego May 6 (Reuters) - WACKER CHEMIE AG WCHG.DE : WACKER EXPANDS PRODUCTION CAPACITY FOR BIOPHARMACEUTICALS IN SAN DIEGO WACKER BIOTECH US, A SUBSIDIARY SPECIALIZING IN THE FERMENTATIVE PRODUCTION OF PLASMID DNA (PDNA), IS EXPANDING ITS MRNA AND PROTEIN PRODUCTION Further compa
W

Wacker Chemie beats Q1 core profit expectations as orders pick up

UPDATE 2-Wacker Chemie beats Q1 core profit expectations as orders pick up Adds analyst comment in paragraph 3, details about silicon division in paragraph 6, share movement in paragraph 10 April 25 (Reuters) - German chemical company Wacker Chemie WCHG.DE reported a 39% fall in first-quarter core profit on Thursday, largely due to lower selling prices, but still beat analysts' expectations on the back of an increase in orders and cost-cutting measures.
W

Wacker Chemie Q1 core profit beats expectations as orders pick up

Wacker Chemie Q1 core profit beats expectations as orders pick up April 25 (Reuters) - German chemical company Wacker Chemie WCHG.DE on Thursday reported a 39% fall in first-quarter core profit largely due to lower selling prices, but still beat analysts' expectations, aided by an increase in orders and by cost-cutting measures. The specialty chemicals maker reported earnings before interest, taxes, depreciation and amortisation (EBITDA) of 172 million euros ($184.16 million), compared to 281 mi
W

BASF, Cadeler, Edenred

EUROPE RESEARCH ROUNDUP-BASF, Cadeler, Edenred April 10 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including BASF, Cadeler and Edenred, on Wednesday. HIGHLIGHTS * BASF BASFn.DE : Deutsche Bank cuts to hold from buy * Cadeler A/S CADLR.OL : Jefferies raises target price to NOK 70 from NOK 65 * Edenred EDEN.PA : Jefferies initiates coverage with underperform rating; PT EUR 40 * Troax Group AB (Publ) TROAX.ST : Berenberg initiates coverage
A
A
A
B
B
B
E
E
E
G
H
H
I
I
K
L
M
P
R
R
R
S
S
S
S
S
V
W
B
M
S

Citi says it's constructive on European chemicals ahead of cyclical recovery

BUZZ-Citi says it's constructive on European chemicals ahead of cyclical recovery ** Citi says it is "constructive but not outright bullish" on European chemicals makers, as it weighs the start of a potential volume recovery against structural concerns ** China becoming self-sufficient in chemicals will drive oversupply, the broker warns ** It says Elkem ELK.OL ("neutral") will struggle slightly as the silicones it specialises in are particularly oversupplied ** Citi raises Evonik EVKn.DE to "bu
A
C
L
W

Azelis, Drax Group, Rentokil Initial

EUROPE RESEARCH ROUNDUP-Azelis, Drax Group, Rentokil Initial April 8 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Azelis, Drax Group and Rentokil Initial on Monday. HIGHLIGHTS * Azelis AZE.BR : JP Morgan raises target price to EUR 27 from EUR 25.5 * Drax Group Plc DRX.L : HSBC raises target price to 500p from 470p * Rentokil Initial RTO.L : HSBC cuts target price to 480p from 495p * Volvo AB VOLVb.ST : Jefferies raises to buy fr
A
A
A
A
B
B
B
C
C
C
D
D
E
G
G
H
H
H
K
L
L
L
M
N
P
R
S
S
S
T
V
W
Z
A
A
B
D
F
P
P
S

Wacker Chemie And Pantherna Expand Collaboration In The Development And Production Of Mrna Biopharmaceuticals

BRIEF-Wacker Chemie And Pantherna Expand Collaboration In The Development And Production Of Mrna Biopharmaceuticals April 5 (Reuters) - WACKER CHEMIE AG WCHG.DE : WACKER AND PANTHERNA EXPAND COLLABORATION IN THE DEVELOPMENT AND PRODUCTION OF MRNA BIOPHARMACEUTICALS IN THE FUTURE, AN ACTIVE INGREDIENT BASED ON MRNA AND LIPID NANOPARTICLES (LNP) AGAI
W



Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.